Microbot Medical Inks Three-Year Distribution Deal With Medtechnica To Advertise, Sell LIBERTY System In Israel

Microbot Medical Inc. (Nasdaq: MBOT) has signed a three-year exclusive distribution agreement with Medtechnica Ltd. to market and sell its LIBERTY Endovascular Robotic System in Israel. The agreement follows regulatory approval from the Israeli Ministry of Health's AMAR Division, with the product registered in the Israeli Medical Device Registry in May 2026. Initial orders from Medtechnica are expected in the fourth quarter of 2026.